Synthesis of Gefitinibfrom Methyl 3-Hydroxy-4-methoxy-benzoate
This paper reports a novel synthesis of gefitinib starting from methyl3-hydroxy-4-methoxybenzoate. The process starts with alkylation of the starting material, followed by nitration, reduction, cyclization, chlorination and two successive amination reactions. The intermediates andtarget molecule wer...
Main Authors: | Ming Dong Li, You Guang Zheng, Min Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2007-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/12/3/673/ |
Similar Items
-
mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy
by: Yan Zheng, et al.
Published: (2017-10-01) -
The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)
by: Zhonghan Zhang, et al.
Published: (2019-11-01) -
Not COVID-19, Don’t Overlook Pneumocystis in Patients on Gefitinib!
by: Jérémy Barben, et al.
Published: (2021-02-01) -
Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study
by: Qian J, et al.
Published: (2020-05-01) -
Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats
by: Aliyah Almomen, et al.
Published: (2020-09-01)